• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-2202-45
Device Problems Fracture (1260); Material Twisted/Bent (2981)
Patient Problems No Code Available (3191); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/02/2020
Event Type  malfunction  
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported that the patient underwent a revision procedure to replace a fractured lead that was slightly bent.Following the procedure the patient was noted to be doing well.
 
Manufacturer Narrative
Device technical analysis: the returned lead was analyzed and revealed the distal tip of the lead is slightly curved.However, the distal end straightness specification was checked, and was confirmed to be still within the specification.The lead has a displacement of less than 1.3 mm relative to the vertical.Investigation conclusion: the investigation concluded that the reported event of the lead being slightly bent was confirmed, however the lead was confirmed to be within the specification, and exhibits normal characteristics and no problem was detected.
 
Event Description
It was reported that the patient underwent a revision procedure to replace a fractured lead that was slightly bent.Following the procedure the patient was noted to be doing well.
 
Event Description
It was reported that the patient underwent a revision procedure to replace a fractured lead that was slightly bent.Following the procedure the patient was noted to be doing well.
 
Manufacturer Narrative
Correction to block h10 - device analysis conclusion device technical analysis: the returned lead was analyzed and revealed the distal tip of the lead is slightly curved.However, the distal end straightness specification was checked, and was confirmed to be still within the specification.The lead has a displacement of less than 1.3 mm relative to the vertical.Investigation conclusion: the investigation concluded that the reported event of the lead being fractured couldn't be confirmed.Visual inspection of the lead revealed that it is not fractured.However the reported event of lead being slightly bent was confirmed yet engineers determined it to be within the specification, and exhibits normal characteristics and no problem was detected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE CARTESIA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
MDR Report Key11038602
MDR Text Key222394190
Report Number3006630150-2020-06270
Device Sequence Number1
Product Code NHL
UDI-Device Identifier08714729905288
UDI-Public08714729905288
Combination Product (y/n)N
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 02/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date06/16/2022
Device Model NumberDB-2202-45
Device Catalogue NumberDB-2202-45
Device Lot Number7074076
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/20/2021
Initial Date Manufacturer Received 12/10/2020
Initial Date FDA Received12/18/2020
Supplement Dates Manufacturer Received02/02/2021
02/19/2021
Supplement Dates FDA Received02/17/2021
02/19/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-